EP0737068B1 2,3-DIARYL-1-BENZOPYRANS FOR TREATING DERMATITIS
US6268367: Piperazine derivatives for treating bone deficit conditions
EP0977571A1 PIPERAZINE DERIVATIVES FOR TREATING BONE DEFICIT CONDITIONS
EP0688214B1 METHODS FOR INHIBITING BONE LOSS WITH 3,4-DIARYLCHROMAN
US5747059 Atrophy of skin/mucous membrane
EP0873121A1 USE OF 3,4-DIPHENYL CHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF ATROPHY OF SKIN AND/OR MUCOUS MEMBRANES
EP0873120A1 USE OF 3,4-DIPHENYL CHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF MENOPAUSAL SYMPTOMS
WO9725036A1 USE OF 3,4DIPHENYL CHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF ATROPHY OF SKIN AND/OR MUCOUS MEMBRANES
WO9725035A1 USE OF 3,4DIPHENYL CHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF MENOPAUSAL SYMPTOMS
US5698521 Native calcitonin mimetics
US5677334 Method for inhibiting the stimulation of a glucagon-induced response pathway in a warm-blooded animal in need thereof
EP0804190A1 USE OF 3,4-DIPHENYL CHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF GYNAECOLOGICAL DISORDERS
WO9621444A1 USE OF 3,4-DIPHENYL CHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF GYNAECOLOGICAL DISORDERS
US5583143 Methods for inhibiting calmodulin activity
US5552413 Methods for inhibiting hyperproliferation of keratinocytes
US5510459 Glucagon antagonists
US5508304 Glucagon antagonists and methods relating thereto
US5480903 3,4-diarylchromans for inhibiting calmodulin activity
EP0737068A1 2,3-DIARYL-1-BENZOPYRANS FOR TREATING DERMATITIS
EP0567562B1 METHODS FOR DETECTING GLUCAGON ANTAGONISTS
WO9517891A1 2,3-DIARYL-1-BENZOPYRANS FOR TREATING DERMATITIS
US5464862 Method for inhibiting bone loss using centchroman derivatives
US5451603 3,4-diarylchromans for treatment of dermatitis
US5416098 Method for treating dermatitis and related conditions
US5408037 Methods for detecting glucagon antagonists
EP0688215A1 3,4-DIARYLCHROMANS FOR TREATMENT OF DERMATITIS
EP0688214A1 METHODS FOR INHIBITING BONE LOSS WITH 3,4-DIARYLCHROMAN
EP0658170A1 GLUCAGON ANTAGONISTS AND METHODS FOR DETECTING GLUCAGON ANTAGONISTS
WO9420099A1 3,4-DIARYLCHROMANS FOR TREATMENT OF DERMATITIS
WO9420098A1 METHODS FOR INHIBITING BONE LOSS WITH 3,4-DIARYLCHROMAN
WO9414427A3 USE OF SKYRIN AND ANALOGUES FOR THE TREATMENT OF DIABETES MELLITUS AND PROCESS FOR THEIR
WO9414427A2 USE OF SKYRIN AND ANALOGUES FOR THE TREATMENT OF DIABETES MELLITUS AND PROCESS FOR THEIR PREPARATION
WO9405699A1 GLUCAGON ANTAGONISTS AND METHODS FOR DETECTING GLUCAGON ANTAGONISTS
US5280040 Methods for reducing bone loss using centchroman
EP0567562A1 METHODS FOR DETECTING GLUCAGON ANTAGONISTS
WO9212998A1 METHODS FOR DETECTING GLUCAGON ANTAGONISTS